MedTrace Logo

Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood

NCT02153515 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-10-13

No results posted yet for this study

Summary

To investigate if fresh finger prick autologous blood (FAB) instead of serum from venesection, is a safe and effective treatment for dry eyes and corneal ulcers/ epithelial defects. Currently there are no studies on the use of whole fresh blood for the treatment of chronic ulcers, persistent epithelial defects or dry eyes. Unpublished case reports indicate that fresh blood can be an effective tool to the treatment of corneal pathology.

Conditions

  • Dry Eyes
  • Sjogren's Disease With Dry Eyes
  • Persistent Corneal Epithelial Defects
  • Chronic Corneal Ulcers

Interventions

OTHER

Your own ( autologous) finger prick of blood produced with a diabetic lancet

Sponsors & Collaborators

  • Moorfields Eye Hospital NHS Foundation Trust

    collaborator OTHER

  • The Mater Infirmary Hospital Belfast, UK.

    collaborator UNKNOWN

  • Milton Keynes University Hospital NHS Foundation Trust

    collaborator OTHER_GOV

  • Heart of England NHS Trust

    collaborator OTHER

  • University Hospitals Bristol and Weston NHS Foundation Trust

    collaborator OTHER

  • Birmingham Midland Eye Centre

    collaborator OTHER

  • Bedford Hospital NHS Trust

    lead OTHER

Principal Investigators

  • Anant Sharma, FRCOphth · Moorfields Eye Hospital NHS Trust and Bedford Hospital NHS Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-08-31
Completion
2017-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02153515 on ClinicalTrials.gov